Cargando…
Prothrombotic immune thrombocytopenia after COVID-19 vaccination
We report 5 cases of prothrombotic immune thrombocytopenia after exposure to the ChAdOx1 vaccine (AZD1222, Vaxzevria) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients presented 5 to 11 days after first vaccination. The spectrum of clinical manifestations included cerebr...
Autores principales: | Tiede, Andreas, Sachs, Ulrich J., Czwalinna, Andreas, Werwitzke, Sonja, Bikker, Rolf, Krauss, Joachim K., Donnerstag, Frank, Weißenborn, Karin, Höglinger, Günter, Maasoumy, Benjamin, Wedemeyer, Heiner, Ganser, Arnold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084604/ https://www.ncbi.nlm.nih.gov/pubmed/34323939 http://dx.doi.org/10.1182/blood.2021011958 |
Ejemplares similares
-
Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia
por: Panagiota, Victoria, et al.
Publicado: (2022) -
Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests
por: Ehrenbauer, Alena F., et al.
Publicado: (2023) -
Azd-1222: Prothrombotic immune thrombocytopenia: case report
Publicado: (2022) -
Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)
por: Thaler, Johannes, et al.
Publicado: (2021) -
von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model
por: Oleshko, Olga, et al.
Publicado: (2023)